Mahir Karababa

Scientific Lead

Mahir Karababa has a PhD in biology from the University of Lausanne. Following a decade in academic research (molecular and cellular biology, inflammation, rheumatoid Arthritis), he gained expertise as regulatory Affairs in various pharma companies for over 12 years. Since 2019, Mahir became a consultant with expertise in rare disease, oncology and cardiology.